Tyrosol and hydroxytyrosol are absorbed from moderate and sustained doses of virgin olive oil in humans

European Journal of Clinical Nutrition

Volumn 57, Issue 1, 2003, Pages 186-190

  Miro Casas E ^a   Covas, M I ^a   Fito M ^a   Farre Albadalejo M ^a   Marrugat, J ^a   de la Torre, R ^a  

^a INST MUNIC D INVESTIGACIO MEDICA   (Spain)

Author keywords

Hydroxytyrosol; Mediterranean diet; Olive oil; Phenolic compounds; Tyrosol

Indexed keywords

BIOLOGICAL MARKER; HYDROXYTYROSOL; OLIVE OIL; PHENOL DERIVATIVE; TYROSOL;

ADULT; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; FAT INTAKE; FEMALE; HUMAN; HUMAN EXPERIMENT; INGESTION; LIPID ABSORPTION; MALE; NORMAL HUMAN; SPAIN; TIME; URINARY EXCRETION;

ADULT; ANTIOXIDANTS; BIOLOGICAL MARKERS; DIET RECORDS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; INTESTINAL ABSORPTION; MALE; METABOLIC CLEARANCE RATE; MIDDLE AGED; NUTRITIVE VALUE; PHENYLETHYL ALCOHOL; PLANT OILS;

EID: 12244313875     PISSN: 09543007     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ejcn.1601532     Document Type: Article

References (23)

1. Caruso D, Berra B, Giavarini F, Cortesi N, Fedeli E & Galli G (1999): Effect of virgin olive oil compounds on in vitro oxidation of human low density lipoproteins. Nutr. Metab. Cardiovasc. Dis. 9, 102-107.
2. Deiana M, Aruoma OI, Spencer JP, Kaur H, Halliwell B, Aeschbach R, Dessi MA & Corongiu FP (1999): Inhibition of peroxynitrite dependent DNA base modification and tyrosine nitration by extra virgin olive oil-derived antioxidant hydroxytyrosol. Free Rad. Biol. Med. 26, 762-769.
3. De la Puerta R, Ruíz-Gutierrez V & Hoult JR (1999): Inhibition of leukocyte 5-lipoxygenase by phenolics from virgin olive oil. Biochem. Pharmac. 57, 445-449.
4. Fitó M, Covas MI, Lamuela-Raventós RM, Vila J, Torrents J, de la Torre C & Marrugat J (2000): Protective effect of olive oil and its phenolic compounds against low density lipoprotein oxidation. Lipids 35, 633-638.
5. Giovannini C, Straface E, Modesti D, Coni E, Cantafora A, de Vincenzi M, Malorni, W & Masella R (1999): Tyrosol, the major olive oil biophenol, protects against oxidized-LDL induced injury in Caco-2 cells. J. Nutr. 129, 1269-1277.
6. Goldstein DS, Swohoda KJ, Miles JM, Coppack SW, Nemman A, Holmes C, Lamensdorf I & Eisenhofer G (1999): Sources and physiological significance of plasma dopamine sulfate. J. Clin. Endocrinol. Metab. 84, 2528-2531.
7. Hedelin H, Grenabo L & Pettersson S (1986): The effects of urease in undiluted human urine. J. Urol. 136, 743-745.
8. Lamensdorf I, Eisenhofer G, Harvey-White J, Nechustan A, Kirk K & Kopin IJ (2000): 3,4-Dihydroxyphenylacetaldehyde potentiates the toxic effects of metabolic stress in PC12 cells. Brain Res. 868, 191-201.
9. Manna C, Della Ragione F, Cucciolla V, Borriello A, D'Angelo S, Galletti P & Zappia V (1999): Advances in Nutrition and Cancer 2, ed. V Zappia, F Della Ragione, A Barbarisi, GL Russo and R Dello Iacovo, pp 115-130. New York: Kluwer Academic/Plenum Publishers.
10. Manna C, Galletti P, Maisto G, Cucciolla V, D'Angelo S & Zappia V (2000): Transport mechanism and metabolism of olive oil hydroxytyrosol in Caco-2 cells. FEBS Lett. 470, 341-344.
11. Mardh G & Vallee BL (1986): Human class I lcohol dehydrogenases catalyze the interconversion of alcohols and aldehydes in the metabolism of dopamine. Biochemistry 25, 7279-7282.
12. Miró-Casas E, Farré Albadalejo M, Covas Planells MI, Fitó Colomer M, Lamuela Raventós R & de la Torre R (2001a): Tyrosol bioavailability in humans after ingestion of virgin olive oil. Clin. Chem. 47, 341-343.
13. Miró-Casas E, Farré Albadalejo M, Covas MI, Ortuño Rodriguez J, Menoyo Colomer E, Lamuela Raventós R & de la Torre R (2001b): Capillary gas chromatography-mass spectrometry quantitative determination of hydroxytyrosol and tyrosol in human urine after olive oil intake. Anal. Biochem. 294, 63-72.
14. Novella-Rodríguez S, Veciana-Nogués MT & Vidal-Carou MC (2000): Biogenic amines amd polyamines in milks and cheeses by ion-pair high performance liquid chromatography. J. Agric. Food Chem. 48, 5117-5123.
15. Owen RW, Mier W, Giacosa A, Hull WE, Spiegelhalder B & Bartsch H (2000): Phenolic compounds and squalene in olive oils: the concentration and antioxidant potential of total phenols, simple phenols, secoroids, lignans and squalene. Food Chem. Toxicol. 38, 647-659.
16. Renaud S, de Lorgeril M, Delaye M, Guidollet J, Jacquard F, Mamelle N, Martin JL, Monjaud I, Salen P & Toubol P (1995): Cretan Mediterranean diet for prevention of coronary heart disease. Am. J. Clin. Nutr. 61, 1360-1365.
17. Salami M, Galli C, de Angelis L & Visioli F (1995): Formation of F2-isoprostanes in oxidized low density lipoprotein: inhibitory effect of hydroxytyrosol. Pharmac. Res. 31, 275-279.
18. Singleton VL & Ross JA (1965): Colorimetry of total phenolics with phosphomolybdic-phosphotungstic acid reagent. Am. J. Enol. Vitic. 16, 144-158.
19. Tsimidou M, Papadopoulos G & Boskou D (1992): Determination of phenolic compounds in virgin olive oil by reversed-phase HPLC with emphasis on UV detection. Food Chem. 44, 53-60.
20. Tuck KL, Freeman MP, Hayball PJ, Stretch GL & Stupans I (2001): The in vivo fate of hydroxytyrosol and tyrosol, antioxidant phenolic constituents of olive oil, after intravenous and oral dosing of labeled compounds to rats. J. Nutr. 131, 1993-1996.
21. Visioli F, Bellomo G, Montedoro G & Galli C (1995): Low density lipoprotein oxidation is inhibited in vitro by olive oil constituents. Atherosclerosis 117, 25-32.
22. Visioli F, Galli C, Bornet F. Mattei A, Patelli R, Galli G & Caruso D (2000): Olive oil phenolics are dose-dependently absorbed in humans. FEBS Lett. 468, 159-160.
23. Vissiers MN, Zock PL, Roodenburg AJ, Leenen R & Katan MB (2002): Olive oil phenols are absorbed in humans. J. Nutr. 132, 409-417.